Associate Professor Jonathan Emberson
BA, MSc, PhD
Associate Professor, Medical Statistics and Epidemiology
- MRC PHRU Programme Leader
- NDPH Deputy Director of Graduate Studies
- Clinical Trial Service Unit
- MSc in Global Health Science Module Lead: Clinical Trials and Meta-Analysis
Jonathan is an Associate Professor of Medical Statistics and Epidemiology within the Nuffield Department of Population Health. After graduating in Mathematics in 1998, he studied statistics and epidemiology at MSc and PhD level before joining the Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU) in 2004.
His main research involves studying the causes and prevention of cardiovascular diseases through the design, conduct and analysis of large-scale observational cohort studies, randomised controlled trials, and individual-participant-data meta-analyses of both types of study. In particular, he is the UK Principal Investigator and MRC Population Health Research Unit (MRC-PHRU) Programme Leader for the Mexico City Prospective Study, a blood-based prospective cohort study of 150,000 Mexican adults followed for more than 15 years.
Cost-effectiveness of lowering LDL cholesterol with statins and ezetimibe in chronic kidney disease
SCHLACKOW I. et al, (2019), Kidney International
Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials.
Cholesterol Treatment Trialists' Collaboration None., (2019), Lancet, 393, 407 - 415
Adiposity and vascular-metabolic mortality among 150,000 Mexican adults followed for 15 years
GNATIUC L. et al, (2018)
Coronary heart disease in relation to general and central adiposity in the UK Biobank: A cohort study of 500 000 men and women
Malden D. et al, (2018), EUROPEAN HEART JOURNAL, 39, 852 - 852
Effect of diabetes duration and glycaemic control on 14-year cause-specific mortality in Mexican adults: a blood-based prospective cohort study.
Herrington WG. et al, (2018), Lancet Diabetes Endocrinol, 6, 455 - 463